Live Breaking News & Updates on Inhaled interferon

Synairgen : IDWeek 2023 Poster Presentation -October 12, 2023 at 12:55 pm EDT

The Effect of Inhaled Interferon Beta-1a Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in COPD Patients with Respiratory Virus Infections
.

Manchester , United-kingdom , Valeroet-al , University-of-manchester , University-of-hull , University-of-glasgow , University-of-southampton , Synairgen-research-ltd , Inhaled-interferon , Treatment-compared , Lung-antiviral-biomarkers , Viral-clearance

Synairgen : ATS 2023 SPRINTER Poster Presentation

Lack of significant systemic tolerability concerns consistent with

• The aim of the inhaled route of. | May 23, 2023

Clinical-trial-findings-support-further-development , Summary-of-clinical-development , Inhaled-interferon , Severe-viral-lung-infections , Clinical-development , Clinical-safety-database , Synairgen-plc-stock-exchange , News , Nformation , Ress-release , Ack